Still hungry on Wegovy 25mg — what's actually going on

Oral semaglutide's appetite effect peaks differently in each person — some feel it strongly from 9mg, others notice it most at 25mg, and a small number find it incomplete even there.
In the OASIS 4 phase 3 trial, average weight loss on 25mg oral semaglutide was around 13.6% over 64 weeks alongside lifestyle changes, with higher loss among those who adhered fully, confirming meaningful but variable effects.
Hunger returning mid-week between doses, or feeling stronger than expected, can signal how food choices, stress, sleep and dose timing interact with the medicine.
Wegovy tablets must be taken first thing in the morning on an empty stomach, with a small amount of plain water, waiting at least 30 minutes before eating, missing this window reduces absorption and can make hunger feel worse.

Feeling hungry on the 25mg Wegovy tablet is more common than people expect, and it doesn't mean the medicine has stopped working. The 25mg dose is the maintenance dose of oral semaglutide, licensed in the UK as Wegovy tablets, and trial data show appetite suppression varies between individuals even at maximum dose. If food feels more appealing than it did at lower doses, there are a few well-understood reasons for that. These are prescription-only medicines; a clinician decides whether the dose or your treatment plan needs adjusting.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why hunger persists at 25mg and what you can do about it

What the OASIS 4 trial data tell us about appetite at the top dose

The phase 3 OASIS 4 trial, which Novo Nordisk cited when the MHRA approved oral semaglutide for weight management in June 2026, enrolled 307 adults with obesity or overweight and at least one weight-related condition. Over 64 weeks, participants taking 25mg oral semaglutide lost around 13.6% of body weight on average compared with about 2.4% on placebo. Among those who adhered fully to the regimen, average loss reached around 16.6%. That gap matters here: it tells you that how consistently you take the tablet, and under the right conditions, influences how much the medicine does.

The trial didn't measure hunger scores as a primary endpoint, but the weight-loss variance across participants points to real differences in how strongly individuals respond at any given dose. Reduced appetite is the mechanism through which semaglutide works, but the reasons hunger persists despite that mechanism are worth understanding before drawing conclusions about whether the dose is right for you.

The NHS medicines page for semaglutide explains that the medicine slows gastric emptying and signals fullness through GLP-1 receptors, effects that are real but that sit on top of your body's own hunger hormones, which don't simply switch off. [NHS: Semaglutide]

The absorption window: the detail most people miss

There is a misconception worth addressing plainly: many people assume that because 25mg is the highest dose, any remaining hunger must mean the medicine has failed. It usually doesn't. The more likely culprits are practical ones.

Oral semaglutide's absorption depends on tight conditions. The tablet needs to be taken first thing in the morning on an empty stomach, with a small amount of plain water, with at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medicines. Coffee before the 30-minute window closes, a small sip of juice with the tablet, or taking it after a glass of milk, any of these reduce how much semaglutide actually reaches your bloodstream. More detail on how Wegovy works explains the mechanism, but the practical upshot is simple: a tablet taken in imperfect conditions is a lower-dose tablet in effect.

If your 25mg dose is being absorbed well, the appetite effect tends to be most noticeable in the hours after taking the tablet and tapers slightly through the day. Feeling hungrier in the evening is normal and not a sign of treatment failure. What you eat matters too: food choices on Wegovy can meaningfully extend or undermine the satiety effect across a day.

When hunger at 25mg is a signal worth discussing with your prescriber

There is a difference between hunger that is manageable and background noise, and hunger that feels indistinguishable from life before treatment. The former is expected. The latter is worth a clinical conversation.

A few things that can blunt semaglutide's appetite effect even at 25mg: chronic sleep deprivation raises ghrelin (a hunger-stimulating hormone) enough to partly override GLP-1 signalling; high stress does something similar via cortisol; diets very low in protein tend to increase hunger on any weight-loss medicine because protein is the most satiating macronutrient. Some people find appetite virtually disappears on this treatment, and others (even at the same dose) find it gentler. Both experiences sit within the trial evidence.

If after a month at 25mg your hunger feels unchanged from baseline, or if hunger has returned after working well at a lower dose, tell your prescriber. They may review your dose timing, assess whether a different treatment suits you better, or simply confirm the treatment is doing what it should at a slower pace. At nume, a GPhC-registered prescriber reviews every repeat order and every clinical query, a real clinician reads your case, not a bot.

For anyone considering starting oral semaglutide or switching from the injection, our guide to managing hunger on Wegovy is worth reading alongside our free consultation, which walks through eligibility and whether Wegovy tablets are the right fit for your situation. Prescription-only medicines deserve that level of review.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions